Safety and feasibility of carboplatin and paclitaxel in combination with nintedanib for non-small cell lung cancer patients with idiopathic pulmonary fibrosis: a prospective pilot...

por Makiguchi, Tomonori, Tanaka, Hisashi, Okudera, Koichi, Taima, Kageaki, Tasaka, Sadatomo
Publicado 2023

Feasibility and safety of platinum-doublet therapy in patients with small-cell lung cancer in the third-line setting: A multi-institutional retrospective study

por Fukushima, Takashi, Makiguchi, Tomonori, Tanaka, Yusuke, Chubachi, Kei, Ishidoya, Mina, Suzuki, Sachio, Tanaka, Hisashi, Taima, Kageaki, Hasegawa, Yukihiro, Okudera, Koichi, Tasaka, Sadatomo
Publicado 2022

A single-arm phase II study of nab-paclitaxel for patients with chemorefractory non-small cell lung cancer

por Tanaka, Hisashi, Taima, Kageaki, Morimoto, Takeshi, Tanaka, Yoshihito, Itoga, Masamichi, Nakamura, Kunihiko, Hayashi, Akihito, Kumagai, Mika, Yasugahira, Hideo, Mikuniya, Megumi, Okudera, Koichi, Takanashi, Shingo, Tasaka, Sadatomo
Publicado 2017

The efficacy of nintedanib in 158 patients with idiopathic pulmonary fibrosis in real-world settings: A multicenter retrospective study

por Dobashi, Masaki, Tanaka, Hisashi, Taima, Kageaki, Itoga, Masamichi, Ishioka, Yoshiko, Shiratori, Toshihiro, Okumura, Fumihiko, Tabe, Chiori, Tanaka, Yoshihito, Morimoto, Takeshi, Hasegawa, Yukihiro, Yasugahira, Hideo, Okudera, Koichi, Takanashi, Shingo, Tasaka, Sadatomo
Publicado 2021